enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral genetic medicines company, today announced that Alex Nichols, Ph.D., Chief Strategy and Operations Officer, will present at the Piper Sandler 37th Annual Healthca
(Financial Post, 2025-11-25T12:30:43Z)